Resources

Resource types
  • Resource types

  • Applications

  • Resource types

  • Applications

6-base ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumour transcription and resistance phenotypes in metastatic prostate cancer
Integrated genetic and methylation analysis reveals how either mutational or epigenetic silencing drives disease 
This review covers the epigenetic influence of 5mC and 5hmC including recent findings connecting these modifications to disease processes and the potential of 6-base sequencing technologies to deepen our understanding of genetics and health.
Exciting news, Professor Anjana Rao’s lab at La Jolla Institute for Immunology has published a new study with Nature Structural & Molecular Biology. Learn how 6-base sequencing can reveal early biomarkers of genome dysfunction.
Assistant Professor Emily Hodges' lab at Vanderbilt University used differentiating neural stem cells as a model system to understand the relationship between DNA methylation and genome dynamics.
Learn how Associate Professor Alex Bick's lab at Vanderbilt University Medical Center conducted a multiracial meta-analysis of epigenome-wide association studies (EWAS) of Clonal Hematopoiesis of Indeterminate Potential (CHIP).
Our study investigates the roles of 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) as biomarkers for early-stage colorectal cancer (CRC) detection in cell-free DNA (cfDNA).
We are extremely proud to announce that our paper ‘Simultaneous sequencing of genetic and epigenetic bases in DNA’ has been published by the journal Nature Biotechnology.

What are you looking for?